SARAH PETTY: Open Payments
NPI 1093361271 · MURRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 45 payments from 11 companies in 2025. Trend: 2023 $1,042 · 2024 $751 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $184 |
| Novo Nordisk Inc | 11 | $150 |
| AstraZeneca Pharmaceuticals LP | 4 | $148 |
| Novartis Pharmaceuticals Corporation | 5 | $81 |
| PFIZER INC. | 4 | $66 |
| Lilly USA, LLC | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: AIRSUPRA, UBRELVY, LEQVIO, Wegovy, QULIPTA, Ozempic, VRAYLAR, PREVNAR 20.
Industry payments across KY — which companies pay providers there.
